Omalizumab (xolair) in treatment resistant bullous pemphigoid

被引:0
|
作者
Blake, S. [1 ,2 ]
Murrell, D. [1 ,2 ]
机构
[1] Univ New South Wales, Sydney, NSW, Australia
[2] St George Dept Dermatol, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:20 / 20
页数:1
相关论文
共 50 条
  • [41] Xolair (omalizumab) in Treatment of Severe Refractory Chronic Idiopathic Urticaria
    Sussman, G.
    Leader, N.
    Merman, E.
    Melvin, R.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB101 - AB101
  • [42] Biological treatment for bullous pemphigoid
    Oren-Shabtai, Meital
    Mimouni, Daniel
    Nosrati, Adi
    Atzmony, Lihi
    Kaplan, Baruch
    Barzilai, Aviv
    Baum, Sharon
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] ERYTHROMYCIN TREATMENT FOR BULLOUS PEMPHIGOID
    MENSING, H
    KRAUSSE, S
    [J]. MEDIZINISCHE KLINIK, 1990, 85 (08) : 481 - 484
  • [44] AZATHIOPRINE IN TREATMENT OF BULLOUS PEMPHIGOID
    GREAVES, MW
    BURTON, JL
    MARKS, J
    DAWBER, RPR
    [J]. BRITISH MEDICAL JOURNAL, 1971, 1 (5741): : 144 - &
  • [45] Bullous pemphigoid treatment review
    Patton, Timothy
    Korman, Neil J.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (17) : 2403 - 2411
  • [46] FDA Approves Xolair® (omalizumab) for Urticaria
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (07) : 878 - 879
  • [47] Postvaccinal, Corticosteroid-resistant Bullous Pemphigoid in Infancy: Treatment with Intravenous Immunoglobulin
    Ister, Marielle
    Pouessel, Guillaume
    Ythier, Hubert
    Catteau, Benoit
    Carpentier, Olivier
    [J]. PEDIATRIC DERMATOLOGY, 2014, 31 (04) : E94 - E95
  • [48] Successful Treatment of a Bullous Urticaria with Omalizumab
    Ozturk, Ayse Bilge
    Kocaturk, Emek
    Ozturk, Erman
    [J]. ALLERGOLOGY INTERNATIONAL, 2014, 63 (03) : 495 - 497
  • [49] Omalizumab (xolair) for chronic urticaria.
    Scofield, R. H.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S279 - S279
  • [50] Successful treatment of chronic idiopathic urticaria & Angioedema (CIU), with Xolair (omalizumab)
    Shapiro, C. A.
    Kapetanos, N. S.
    Sarmiento, E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S274 - S274